Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan;61(1):93-106.
doi: 10.1007/s11626-024-00984-2. Epub 2024 Oct 23.

Astragaloside promotes the secretion of MSC-derived exosomal miR-146a-5p by regulating TRAF6/NF-κB pathway to attenuate inflammation in high glucose-impaired endothelial cells

Affiliations

Astragaloside promotes the secretion of MSC-derived exosomal miR-146a-5p by regulating TRAF6/NF-κB pathway to attenuate inflammation in high glucose-impaired endothelial cells

Jiye Chen et al. In Vitro Cell Dev Biol Anim. 2025 Jan.

Abstract

This study aimed to explore the potential of using mesenchymal stem cell (MSC)-derived exosomes (MSC-Exos) pre-treated with Astragaloside IV (ASIV) to alleviate inflammation in high glucose (HG)-damaged endothelial cells. MSC-Exos were isolated from untreated MSCs and ASIV-pre-treated MSCs, and their characteristics were assessed. The expression of miR-146a-5p in MSC-Exos was determined, and it was found that ASIV treatment enhanced its expression. In order to assess the impact of highly miR-146a-5p-expressing MSC-Exos on HG-injured endothelial cells, we established a model of HG-induced inflammation using human umbilical vein endothelial cells (HUVECs). The study measured cell viability, apoptosis, tube formation, and levels of inflammatory cytokines among the different treatment groups. It was found that transferring MSC-Exos with high miR-146a-5p expression to HG-damaged HUVECs increased cell viability and tube formation ability while reducing the number of apoptotic cells. Additionally, changes in inflammatory factors indicated a reduction in the inflammatory response. Further investigation demonstrated that miR-146a-5p inhibited the expression of TNF receptor associated factor 6 (TRAF6) and phosphorylated NF-κB, which are involved in the inflammatory response. This resulted in the alleviation of inflammation in HG-damaged endothelial cells. In summary, our findings indicate that ASIV treatment stimulated the secretion of MSC-Exos that exhibited increased levels of miR-146a-5p. These exosomes, in turn, regulated the TRAF6/NF-κB pathway. As a result of this modulation, the inflammatory response in HG-damaged endothelial cells was alleviated. These findings offer a fresh approach to addressing vascular complications associated with diabetes, which could lead to novel treatment strategies in the field.

Keywords: Astragaloside IV; Diabetes; Exosome; Inflammation; MSC; MiR-146a-5p; TRAF6.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The animal experiment was approved by the Experimental Animal Welfare Ethics Committee of the First Affiliated Hospital of Hunan University of Chinese Medicine (HN-LL-KY-2022–046-01). Patient consent for publication: N/A. Competing interests: The authors declare that there were no conflicts of interest. All authors agreed to submit the manuscript.

Similar articles

Cited by

References

    1. Abdalla M, Sabbineni H, Prakash R, Ergul A, Fagan SC, Somanath PR (2015) The Akt inhibitor, triciribine, ameliorates chronic hypoxia-induced vascular pruning and TGFbeta-induced pulmonary fibrosis. Br J Pharmacol 172(16):4173–4188 - PubMed - PMC
    1. Asami T, Ishii M, Fujii H, Namkoong H, Tasaka S, Matsushita K et al (2013) Modulation of murine macrophage TLR7/8-mediated cytokine expression by mesenchymal stem cell-conditioned medium. Mediators Inflamm 2013:264260 - PubMed - PMC
    1. Auyeung KK, Han QB, Ko JK (2016) Astragalus membranaceus: A Review of its Protection Against Inflammation and Gastrointestinal Cancers. Am J Chin Med 44(1):1–22 - PubMed
    1. Cade WT (2008) Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther 88(11):1322–1335 - PubMed - PMC
    1. Ceriello A (2010) Point: postprandial glucose levels are a clinically important treatment target. Diabetes Care 33(8):1905–1907 - PubMed - PMC

MeSH terms

LinkOut - more resources